EVOFEM BIOSCIENCES INC's ticker is EVFM and the CUSIP is 30048L104. A total of 18 filers reported holding EVOFEM BIOSCIENCES INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $574,000 | -39.8% | 508,148 | -6.8% | 0.20% | -42.0% |
| Q1 2021 | $954,000 | +10.7% | 545,413 | +52.5% | 0.35% | +5.1% |
| Q4 2020 | $862,000 | -24.7% | 357,580 | -26.3% | 0.33% | -37.0% |
| Q3 2020 | $1,145,000 | -16.5% | 485,370 | +0.2% | 0.52% | -24.7% |
| Q2 2020 | $1,371,000 | -50.0% | 484,595 | -6.0% | 0.70% | -58.5% |
| Q1 2020 | $2,741,000 | -16.1% | 515,262 | -2.7% | 1.68% | +11.7% |
| Q4 2019 | $3,266,000 | +22.0% | 529,330 | -0.3% | 1.50% | +20.3% |
| Q3 2019 | $2,676,000 | -24.3% | 531,030 | -0.3% | 1.25% | -24.3% |
| Q2 2019 | $3,537,000 | +90.1% | 532,610 | +0.1% | 1.65% | +78.4% |
| Q1 2019 | $1,861,000 | -16.8% | 531,855 | -0.4% | 0.93% | -28.3% |
| Q4 2018 | $2,237,000 | +2.6% | 533,955 | -0.8% | 1.29% | +39.3% |
| Q3 2018 | $2,181,000 | +188.9% | 538,505 | +93.2% | 0.93% | +175.9% |
| Q2 2018 | $755,000 | – | 278,715 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Taylor Wealth Management Partners | 545,413 | $954,000 | 0.35% |
| HEARTLAND ADVISORS INC | 2,655,400 | $4,647,000 | 0.29% |
| Maven Securities LTD | 2,750,000 | $4,826,000 | 0.22% |
| FIRST WILSHIRE SECURITIES MANAGEMENT INC | 150,000 | $263,000 | 0.10% |
| GSA CAPITAL PARTNERS LLP | 265,286 | $464,000 | 0.08% |
| GREAT LAKES ADVISORS, LLC | 1,697,052 | $2,970,000 | 0.05% |
| CAAS CAPITAL MANAGEMENT LP | 2,335,305 | $4,087,000 | 0.04% |
| Virtu Financial LLC | 174,447 | $305,000 | 0.02% |
| Game Plan Financial Advisors, LLC | 18,500 | $33,000 | 0.02% |
| Baker Brothers Advisors | 2,697,110 | $4,720,000 | 0.02% |